Get started
Author

Hülya Ertaş

Observed names: ERTAŞ, HÜLYA, H. Ertas, Hulya Ertas, Hülya ERTAŞ, Hülya Ertas
ORCID: 0000-0002-5872-8825
Observed ORCID: 0000-0002-5872-8825
OpenAlex ID: A5076316473
Platinum-induced neurotoxicity: A review of possible mechanisms
2017 · Ozkan Kanat, Hulya Ertas, et al. · World Journal of Clinical Oncology · 175
PDF
Shattering the castle walls: Anti-stromal therapy for pancreatic cancer
2018 · Ozkan Kanat, Hulya Ertas · World Journal of Gastrointestinal Oncology · 33
PDF
Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy
2019 · Ozkan Kanat, Hulya Ertas · World Journal of Clinical Oncology · 28
Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations
2020 · Ozkan Kanat, Hulya Ertas, et al. · World Journal of Gastrointestinal Oncology · 11
Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status
2018 · Ozkan Kanat, Hulya Ertas, et al. · World Journal of Clinical Cases · 10
PDF
MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics
2018 · S. Aksoy, O. Kanat, et al. · Annals of Oncology · 5
Hyperprogression and hypercalcemia after nivolumab treatment in three cases with renal cell carcinoma
2022 · Burcu Caner, Hulya Ertas, et al. · Journal of Oncology Pharmacy Practice · 3
Evaluation of the Frequency of Sleep Disorders, Depression and Anxiety in Patients with Early-Stage Breast Cancer: Cross-Sectional Study
2023 · Hülya ERTAŞ, Burcu CANER, et al. · Turkiye Klinikleri Journal of Medical Sciences · 2
PDF
Treatment of adult medulloblastoma: a single-center experience
2026 · Burcu Caner, Hülya Ertaş, et al. · Frontiers in Oncology
PDF
Immune-related Adverse Events and Their Management in Cancer Patients Aged 75 Years and Older Receiving Immunotherapy
2026 · Buket Şahin Çelik, Hülya Ertaş, et al. · Acta Medica Nicomedia
PDF
Prognostic Value of Mean Platelet Volume and MPV-to-Platelet Count Ratio in Patients with Gastric Cancer: A Retrospective Analysis
2026 · Hülya Ertaş, Mehmet Arhan · Indian Journal of Surgical Oncology
Survival Outcomes in Metaplastic Versus Triple-Negative Invasive Breast Carcinoma: A Propensity Score-Matched Study
2026 · Burcu Caner, Hulya Ertas, et al. · Medicina
Prognostic Value of Immunonutritional Status and Radiologic Muscle Mass in Older Patients Receiving Immune Checkpoint Inhibitors: A Real-World Study
2026 · Hülya Ertaş, Burcu Caner, et al. · Current Oncology
Predictors of hepatotoxicity in patients receiving CDK4/6 inhibitors: A real-world cohort study
2026 · Hülya Ertaş, Burcu Caner, et al. · Journal of Oncology Pharmacy Practice
Psychological impact of CDK4/6 inhibitors in HR+/HER2– advanced breast cancer: Insomnia, anxiety and menopausal symptoms assessed by the Nottingham health profile
2026 · Hülya Ertaş, burcu caner, et al. · Irish Journal of Medical Science (1971 -)
Predictive value of morphological, functional, and nutritional markers in elderly patients with advanced squamous cell lung cancer receiving gemcitabine plus carboplatin: A multidimensional "triple-risk" approach
2026 · Hulya Ertas, Burcu Caner, et al. · The Atlantic Journal of Medical Science and Research
PDF
Metastatik Meme Kanserinde Parenteral ve Oral Tedavilerin Psikolojik ve Yaşam Kalitesi Üzerindeki Etkileri: Karşılaştırmalı Analiz
2025 · Hülya Ertaş, Burcu Caner, et al. · Journal of Anatolian Medical Research
PDF
Sleep Disturbance in Breast Cancer Under Chemotherapy: A Multifactorial Analysis Emphasizing Psychosocial Dimensions
2025 · Hülya Ertas, Burcu Caner, et al. · Research Square
PDF
Evaluation of complementary and alternative medicine use in cancer patients: A survey study in Turkey
2025 · Hulya Ertas, Burcu Caner, et al. · Advances in Integrative Medicine
Retrospective Analysis of the Factors Affecting Recurrence, Survival, and Effect of Hippocampus Radiotherapy Doses on Neurocognitive Functions in Patients Diagnosed with Glioblastoma Multiforme
2024 · Sevilcan İnan, Öznur Dönmez Tutanç, et al. · Gazi Medical Journal
PDF
Rektum Kanseri Tanısıyla Radyoterapi ile Eş Zamanlı 5-Florourasil/Kapesitabin Uygulanan Hastaların 10 Yıllık Sağkalımına Etki Eden Faktörlerin Retrospektif Değerlendirilmesi
2023 · Sevilcan İNAN, Meral KURT, et al. · Akdeniz Medical Journal
MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFRtherapeutics
2018 · ÇEÇENER, GÜLŞAH, EGELİ, ÜNAL, et al. · Bursa Uludag University - AVESIS
Works count: 22
Citation count: 267
H-index: 5
I10-index: 5
Year
Topic
Type